Mauna Kea Technologies SA (LON:0P5I)

Market Cap	9.29M
Revenue (ttm)	6.91M
Net Income (ttm)	-9.51M
Shares Out	n/a
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	105
Average Volume	633
Open	0.183
Previous Close	0.180
Day's Range	0.183 - 0.183
52-Week Range	0.136 - 0.429
Beta	1.44
RSI	41.51
Earnings Date	Apr 24, 2025

About Mauna Kea Technologies

Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 68
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P5I

Financial Performance

In 2023, Mauna Kea Technologies's revenue was 11.03 million, an increase of 35.97% compared to the previous year's 8.11 million. Losses were -3.73 million, -66.66% less than in 2022.

Financial numbers in EUR